DNB ASSET MANAGEMENT AS – Vertex Pharmaceuticals Incorporated Transaction History
DNB ASSET MANAGEMENT AS portfolio value:
$91.48M
portfolio value
DNB ASSET MANAGEMENT AS quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.46% | -29.22K shares | -5.78M | $289.54 | 315.98K |
| Q2 2022 | share | Decrease | -1.79% | -6.27K shares | 5.54M | $281.79 | 345.20K |
| Q1 2022 | share | Decrease | -27.96% | -136.41K shares | -15.41M | $260.97 | 351.47K |
| Q4 2021 | share | Decrease | -4.32% | -22.00K shares | 14.65M | $222.45 | 487.89K |
| Q3 2021 | share | Increase | +20.46% | 86.59K shares | 7.13M | $181.39 | 509.90K |
| Q2 2021 | share | Increase | +473.75% | 349.53K shares | 69.49M | $201.63 | 423.30K |
| Q1 2021 | share | Increase | +91.87% | 35.32K shares | 6.76M | $214.89 | 73.77K |
| Q4 2020 | share | Increase | +10.70% | 3.71K shares | -364.10K | $236.34 | 38.45K |
| Q3 2020 | share | Increase | +8.01% | 2.57K shares | 115.71K | $272.12 | 34.73K |
| Q2 2020 | share | Increase | +19.54% | 5.25K shares | 2.93M | $290.31 | 32.16K |
| Q1 2020 | share | Decrease | -16.30% | -5.23K shares | -635.68K | $237.95 | 26.90K |
| Q4 2019 | share | Increase | +15.85% | 4.39K shares | 2.33M | $218.95 | 32.14K |
| Q3 2019 | share | Increase | +7.53% | 1.94K shares | -30.82K | $169.42 | 27.74K |
| Q2 2019 | share | Decrease | -5.96% | -1.63K shares | -315.46K | $183.38 | 25.80K |
| Q1 2019 | share | Decrease | -10.10% | -3.08K shares | -10.61K | $183.95 | 27.43K |
| Q4 2018 | share | Decrease | -6.45% | -2.10K shares | -1.23M | $165.71 | 30.52K |
| Q3 2018 | share | Increase | +3.31% | 1.04K shares | 920.61K | $192.74 | 32.62K |
| Q2 2018 | share | Increase | +8.22% | 2.4K shares | 611.58K | $169.96 | 31.58K |
| Q1 2018 | share | Increase | +11.04% | 2.9K shares | 817.43K | $162.98 | 29.18K |
| Q4 2017 | share | Increase | +2.34% | 600 shares | 33.93K | $149.86 | 26.28K |
| Q3 2017 | share | Decrease | -0.39% | -100 shares | 582.11K | $152.04 | 25.68K |
| Q2 2017 | share | Decrease | -2.64% | -700 shares | 426.68K | $128.87 | 25.78K |
| Q1 2017 | share | Increase | +18.32% | 4.1K shares | 1.24M | $109.35 | 26.48K |
| Q4 2016 | share | Increase | +5.67% | 1.2K shares | -198.37K | $73.67 | 22.38K |
| Q3 2016 | share | Increase | +7.08% | 1.4K shares | 145.63K | $87.21 | 21.18K |
| Q2 2016 | share | Increase | +8.21% | 1.5K shares | 248.39K | $86.02 | 19.78K |
| Q1 2016 | share | Increase | +34.61% | 4.7K shares | -255.69K | $79.49 | 18.28K |